Acuta Capital Partners, LLC Amarin Corp Plcuk Transaction History

Acuta Capital Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $1.39 Million - $2.41 Million	-100,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $1.39 Million - $2.32 Million	100,000 New	100,000 $1.52 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $1.42 Million - $1.79 Million	-87,500 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $4.41 Million - $7.82 Million	-350,000 Reduced 80.0%	87,500 $1.82 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $4.55 Million - $8.42 Million	366,500 Added 516.2%	437,500 $5.95 Million

Q3 2018 Nov 07, 2018	BUY	$2.45 - $16.27 $173,950 - $1.16 Million	71,000 New	71,000 $1.16 Million

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $278M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.